Allison Huegel
Chief Operating Officer
x
Allison Huegel Chief Operating Officer
Allison Huegel is serving as Chief Operating Officer for AxoProtego Therapeutics. Previously, Allison served as co-founder and Chief Operating Officer of Pro ED COMMUNICATIONS, INC., an international pharmaceutical and biotech health science communications company recognized by pharmaceutical industry and health authorities (ie, FDA) as best in class for expertise and service for commercial drug development. Allison oversaw corporate services include clinical and regulatory drug development, scientific and medical publications, medical meetings and event planning, continuing medical education (CME), creative and graphic design, and specialty marketing programs. Allison was responsible for corporate organization structure including finance, accounting, human resources, communication systems, physical facilities, meetings/events, and client troubleshooting. Allison personally devised the team approach that enabled clients to avail a brain trust of experts and staff to best support their product development life cycle.
Jim Sergi
Director Business Development
x
Jim Sergi Director Business Development
Jim Sergi is President of CSSi LifeSciences, a global drug discovery and technology development company providing fully integrated, specialized regulatory and clinical services for pharmaceutical and medical device companies. Prior to this role, Jim held various positions in academic oncology and cancer research before co-founding ProED, a healthcare services and drug development company. Jim has been responsible for over 100 successful NDA/BLA submissions and over 250 medical device approvals. His academic and medical experience includes Director for the Department of Experimental Therapeutics at the Cleveland Clinic Cancer Center, Associate Professor of Medical-Surgical Nursing at the Case Western Reserve University and Lecturer for Oncology at Cleveland State University. He has authored over 50 peer reviewed publications and has numerous issued patents. Jim serves a scientific reviewer for the NIH SBIR/STTR Commercial Readiness Program, as well as a mentor to the NIH/NHLBI and the NIH Larta FeedForward programs. He also serves as a member of the Global Center for Health Innovation and the NoCoBio Task Forces, and as a scientific advisor to numerous private equity and venture backed investment firms.
Chris Trizna
Program Operations
x
Chris Trizna Program Operations
Chris Trizna is the President of CSSi, the only company in the global patient recruitment sector whose focus is on increasing site performance and optimizing patient enrollment. Chris founded CSS in 2005 with a mission to address the pharmaceutical industry’s need for site-specific patient recruitment and enrollment solutions. In 2010 Chris co-founded CSSi, a global patient enrollment company with experience in more than 47 countries, whose focus is providing country-specific enrollment expertise. Chris is considered an industry thought leader; he has presented at numerous conferences and meetings and has been published surrounding the topic of patient enrollment.
Dinar Dhond
Chief Technical Officer
x
Dinar Dhond Chief Technical Officer
Dinar has over 22 years of experience in the information technology field, with experience in different facets of IT including: application development, system engineering, data center operations, etc. Dinar has worked with Fortune 100 companies as part of Oracle, consulting on development and maintenance of mission critical systems. He consulted with companies such as GE Aircraft Systems, OCLC, submitorder.com and World Duty Free. Dinar's project experience includes design and development of data warehousing systems, messaging architecture systems, and high-available database systems. Dinar's development experience in patient access programs include design and development of programs for various Fortune 500 companies. Dinar has several years of experience in development of hub-and-spoke architecture to connect various specialty pharmacies, healthcare providers and pharmaceutical clients for various manufacturer products. Dinar has held several senior level positions at Pharmaceutical Research Plus, Oracle, HealthStar Communications and CSSi. Dinar's academic credentials include a B.S. in Computer Science and an M.B.A.
Ronald M. Bukowski, MD
Chief Medical Officer
x
Ronald M. Bukowski, MD Chief Medical Officer
Dr. Bukowski is an emeritus staff at the Cleveland Clinic Foundation, and Professor of Medicine, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University. He was recently the Deputy Director of the Cleveland Clinic Taussig Cancer Center and Director of the Experimental Therapeutics at the Cleveland Clinic Cancer Center from 2001 to 2008, and is currently an emeritus physician in the Taussig Cancer Center. Dr. Bukowski is a fellow of the American College of Physicians and a member of numerous professional societies, including the American Society of Clinical Oncology, and the American Society of Hematology. He is a lifelong researcher with interests in biologic response modifiers, the biology of renal cell carcinoma, and new drug development and investigation. Currently, Dr. Bukowski is the chairman of the medical committee of the Kidney Cancer Association and chairman of its board of directors.
Heidi Nelson-Keherly, PhD
Chief Scientific Officer
x
Heidi Nelson-Keherly, PhD Chief Scientific Officer
Heidi is a 15 year veteran of working with small and mid-size biotech's to develop their drug programs through to IND submission. She has managed drug development programs spanning preclinical lead optimization, pharmacokinetic and safety studies, bioanalysis, process scale up and development, as well as CMC. During her career, she has been involved with over 300 drug development programs. In addition, Heidi was responsible for several multi-therapeutic clinical research sites that participated in over 80 Phase II-IV clinical trials. Heidi holds a PhD in Molecular Biology from the University of Wisconsin.
Jeff Herndon, CPA, CFA
Chief Financial Officer
x
Jeff Herndon, CPA, CFA Chief Financial Officer
Jeff has over 30 years of experience in accounting and finance. He has held positions at Deloitte & Touche, and The Geneva Companies (now CitiGroup). Jeff has extensive experience in company valuations and been involved in over 30 successful sell-side M&A transactions. Jeff achieved a Bachelor of Science degree in Accounting from the University of South Florida and passed the Certified Public Accounting exam on the first attempt.
Richard A. Moran, PhD
Chief Executive Officer
x
Richard A. Moran, PhD Chief Executive Officer
Richard Moran is a Silicon Valley veteran in both investing and operations. He is General Partner at Tonic BioVentures, an early stage life sciences venture firm. Previously, he was the President of Menlo College. His background includes serving as a Partner at Venrock, CEO at Accretive Solutions, Chairman of Portal Software and a Managing Partner at Accenture. His track record includes successful exits in software, gaming, food and life sciences. He is a best-selling author with ten books to his credit. He has a syndicated show, "In the Workplace" on CBS Radio. He holds a Ph.D. from Miami University in Organization Behavior.
